4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-010756
Chief Dev Operations Officer acquired 9,675 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Frenkel Ran · Chief Dev Operations Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-15 | Exercise or conversion : show line 1 in the form | +9,675 | 39,041 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2020-02-15 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −9,675 | 9,675 | 29,025 | D |
Loading xslF345X03/doc4.xml…